Rare
lephants
Screener
Toggle theme
Nurix Therapeutics, Inc.
NRIX
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
EPS
Compare
←
5Y
10Y
MAX
→
EPS
Chart
Table
EPS
Cyclically Adjusted EPS
Fiscal Year
EPS
Cyclically Adjusted EPS
FY2023
$-2.65
$-4.26
FY2024
$-2.88
$-4.03
FY2025
$-3.05
$-3.89
Download CSV
